Picture of Zydus Lifesciences logo

ZYDUSLIFE — Zydus Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's Zydus Lifesciences gains on strong quarterly results, upbeat brokerage outlook

** Shares of India's Zydus Lifesciences ZYDU.NS jump to 6.15% to 1081.55 rupees

** Co's Q4 consol net profit rose ~8.7% y/y to 12.73 billion rupees ($131.87 million)

** Total revenue from ops rose 16.2%, driven by growth in consumer products, medical technologies segments

** Dolat Capital lifts PT by 96 rupees to 1,182 rupees; raises FY27 and FY28 earnings estimates by 8.6% and 8.9%, respectively, on higher sales, margins

** JPMorgan cuts PT by 10 rupees to 1,050 rupees; raises FY27 earnings estimates by 10% on strong guidance, sees ~15% core EPS CAGR over the next two years

** Jefferies raises FY28 EPS estimates by 14%, citing new product launches

** ZYDU shares closed up 2.8% on Tuesday after results

** YTD, stock up ~11.5%

($1 = 96.5325 Indian rupees)

(Reporting by Bipasha Dey in Bengaluru)

((Bipasha.Dey@thomsonreuters.com;))

Recent news on Zydus Lifesciences

See all news